COO · NASDAQ · STOCK
Cooper Companies (The)
$74.25
52W $58.89 – $89.83
66/100
$14.48B
62.9
0.84
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.
Is COO Bullish or Bearish?
Bullish.
Innellis AI committee rates Cooper Companies (The) (COO) Buy with a composite score of 66/100
, based on 4 analysts with 75% agreement.
Last updated August 08, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +8.66 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -11.34 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is 4 consecutive earnings beats -- consistent execution. The main limiting factor is news sentiment is negative (-0.18 across 11 articles, 14d). The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- News sentiment is negative (-0.18 across 11 articles, 14d) — News
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 08, 2026
Overall Committee Score
66/100
Agreement
75%
Analysts
4
Conviction
High
Sector Rank
Top 15%
of 95 Healthcare peers
Growth Analyst
bullish
82
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
52
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
− News sentiment is negative (-0.18 across 11 articles, 14d)
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 4 existing position pair(s) are highly correlated already
Investment Thesis Evolution
Committee score moved marginally from 67.1 to 66.3.
- New bearish signals: 1 appeared.
Analyst-level changes:
- News Analyst: score 55->52 (-3); +1 bearish signal(s).
Comparing 2026-08-07 to 2026-08-08 (1 day apart).
Technical Analysis
RSI (14)
61.8
Neutral
MACD Histogram
0.112
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Hh Hl
Support
$71.00
Resistance
$74.42
Bollinger %B
0.82
Inside Bands
Price vs Moving Averages
EMA 9
$73.41
Above
EMA 21
$72.22
Above
EMA 50
$70.30
Above
EMA 200
$71.99
Above
Fundamental Analysis
Valuation
65
Growth
79
Profitability
45
Financial Health
70
Cash Flow
70
Valuation
P/E Ratio
62.9×
P/B Ratio
1.76×
PEG Ratio
-1.45
Dividend Yield
0.00%
52W High
$89.83
52W Low
$58.89
Quality & Growth
ROE
455.0%
ROA
302.5%
Gross Margin
6437.1%
Operating Margin
1176.8%
Revenue Growth YoY
—
Debt / Equity
0.30
AI Fundamental Assessment
P/E ratio of 62.9 (rich relative to a 15-40x range); Price-to-book of 1.8x; PEG ratio of -1.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 4.6%; Return on assets of 3.0%; Net margin of 5.6%; Gross margin of 64.4%; Current ratio of 1.27 (tight short-term liquidity); Debt-to-equity of 0.30; Free cash flow per share is positive (2.92); Most recent quarter beat estimates by 9.3%; 4 consecutive earnings beats; EPS growth accelerating (-4.3% -> +10.0% QoQ); Analyst estimates flat over recent quarters
Get the Full COO Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →